ClearPoint Neuro (CLPT) Return on Capital Employed Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 4,734.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,734.00 |
| Dec 31, 2025 | 3,188.00 |
| Sep 30, 2025 | 594.00 |
| Jun 30, 2025 | -701.00 |
| Mar 31, 2025 | -1,459.00 |
| Dec 31, 2024 | -460.00 |
| Sep 30, 2024 | 689.00 |
| Jun 30, 2024 | -154.00 |
| Mar 31, 2024 | -2,467.00 |
| Dec 31, 2023 | -2,989.00 |
| Sep 30, 2023 | -2,536.00 |
| Jun 30, 2023 | -2,083.00 |
| Mar 31, 2023 | -1,361.00 |
| Dec 31, 2022 | -1,134.00 |
| Sep 30, 2022 | -1,227.00 |
| Jun 30, 2022 | -1,531.00 |
| Mar 31, 2022 | -1,047.00 |
| Dec 31, 2021 | 623.00 |
| Sep 30, 2021 | 1,102.00 |
| Jun 30, 2021 | 1,248.00 |
| Mar 31, 2021 | 1,948.00 |
| Dec 31, 2020 | 2,439.00 |
| Sep 30, 2020 | 1,721.00 |
| Jun 30, 2020 | 3,612.00 |
| Mar 31, 2020 | 5,345.00 |
| Dec 31, 2019 | 2,995.00 |
| Sep 30, 2019 | 2,777.00 |
| Jun 30, 2019 | 5,156.00 |
| Mar 31, 2019 | 770.00 |
| Sep 30, 2016 | -168,102.00 |
| Jun 30, 2016 | -647,026.00 |
| Mar 31, 2016 | 112.00 |
| Sep 30, 2015 | 182,911.00 |
| Jun 30, 2015 | 632,724.00 |
| Mar 31, 2015 | -6,054.00 |
| Dec 31, 2014 | -64,212.00 |
| Sep 30, 2014 | -17,458.00 |
| Jun 30, 2014 | -1,452.00 |
| Mar 31, 2014 | 1,122.00 |
| Dec 31, 2013 | 199,600.00 |
| Sep 30, 2013 | -25,569.00 |
| Jun 30, 2013 | -17,826.00 |
| Mar 31, 2013 | -20,045.00 |